Jeanine Kamphuis

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Ketamine addiction following a single sub-anaesthetic ketamine treatment for acute suicidality in a psychiatrically multimorbid patient: case report.

Ketamine addiction following a single sub-anaesthetic ketamine treatment for acute suicidality in a psychiatrically multimorbid patient: case report.

Journal: BJPsych open

Published: April 21, 2026

Insomnia as a risk factor for the development of depression and anxiety in primary care: a matched population-based cohort study.

Insomnia as a risk factor for the development of depression and anxiety in primary care: a matched population-based cohort study.

Journal: Family practice

Published: April 20, 2026

A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice.

A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: March 25, 2026

Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial.

Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial.

Journal: Journal of affective disorders

Published: February 12, 2026

Effects of ketamine on sleep and circadian rhythmicity in major depressive disorder and bipolar disorder: A systematic review.

Effects of ketamine on sleep and circadian rhythmicity in major depressive disorder and bipolar disorder: A systematic review.

Journal: Journal of affective disorders

Published: January 30, 2026

Can Physical Activity, Sleep Parameters, and Sleep-Wake Patterns Predict Outcome of Combined Chronotherapy in Mood Disorder During Routine Clinical Practice? An Exploratory Study.

Can Physical Activity, Sleep Parameters, and Sleep-Wake Patterns Predict Outcome of Combined Chronotherapy in Mood Disorder During Routine Clinical Practice? An Exploratory Study.

Journal: Journal of personalized medicine

Published: December 05, 2025

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Journal: BMJ open

Published: October 08, 2025

The Ketamine Trial for Acute Suicidality (KETA): Study Protocol of a Double-Blind Randomized Placebo-Controlled Superiority Trial on Intranasal Racemic Ketamine Compared to the Active Placebo Intranasal Midazolam as Treatment for Acute Suicidality.

The Ketamine Trial for Acute Suicidality (KETA): Study Protocol of a Double-Blind Randomized Placebo-Controlled Superiority Trial on Intranasal Racemic Ketamine Compared to the Active Placebo Intranasal Midazolam as Treatment for Acute Suicidality.

Journal: International journal of methods in psychiatric research

Published: September 13, 2025

Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach.

Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach.

Journal: Journal of psychiatric research

Published: July 16, 2025

Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review.

Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review.

Journal: Clinical psychology review

Published: May 31, 2025

Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.

Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.

Journal: Journal of psychopharmacology (Oxford, England)

Published: April 26, 2025

Single fixed-dose intranasal racemic ketamine treatment for the treatment of acute suicidality in a transdiagnostic patient population: Results of a pilot study.

Single fixed-dose intranasal racemic ketamine treatment for the treatment of acute suicidality in a transdiagnostic patient population: Results of a pilot study.

Journal: Psychiatry research

Published: March 13, 2025

Showing 1-12 of 50

Last Updated: 09/26/2026